Showing posts with label RXRX. Show all posts
Showing posts with label RXRX. Show all posts
Wednesday, July 23, 2025

Why do Nvidia and so many institutional investors own most of the shares of RXRX - Recursion Pharma

›
  Why Nvidia Invested in RXRX 1. Deep AI Integration for Drug Discovery In July 2023, Nvidia invested $50 million via a PIPE deal to he...
Saturday, May 31, 2025

Here's an aggressive way to enter the Agentic Ai stock race if you're seeking high reward that carries high risk!

›
  here's a high-conviction Agentic AI stock watchlist for an aggressive portfolio, including ideal buy ranges , key catalysts , and wha...
Tuesday, March 11, 2025

Nvidia's interest and investment in Recursion Pharmaceuticals (RXRX) in 2025 could be a game changer for this small-cap!

›
    Recursion Pharmaceuticals (NASDAQ: RXRX) is a clinical-stage biotechnology company that integrates advanced technologies across biology...
Tuesday, September 17, 2024

Investing in Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) at the intersection of biotechnology and advanced computational methods.

›
  Here are several reasons why someone might consider investing in the company: Innovative Drug Discovery Platform : Recursion leverages art...

Here are ten small-cap, publicly traded companies that are incorporating cutting-edge AI technology into healthcare!

›
T en small-cap, publicly traded companies  using cutting edge Ai in to enhance healthcare! iCAD Inc. (NASDAQ: ICAD) iCAD develops advanced A...
Wednesday, July 10, 2024

Two years ago! That was the last time you could buy shares of Recursion Pharmaceuticals (NASDAQ: RXRX) at today's price! Here's why!

›
  Recursion Pharmaceuticals (NASDAQ: RXRX)   recently raised approximately $200 million through a public offering of 30,769,230 shares of it...